U.S. Markets open in 5 hrs 36 mins

United Therapeutics Corporation (UTHR)

NASDAQ Global Select - NASDAQ Global Select Delayed Price. Currency in USD
Add to watchlist
130.72-0.56 (-0.43%)
At close: 4:00PM EDT
People also watch
ALXNBMRNVRTXMDCOMYGN
Full screen
Previous Close131.28
Open130.52
Bid0.00 x 0
Ask0.00 x 0
Day's Range129.81 - 131.30
52 Week Range110.90 - 169.89
Volume333,135
Avg. Volume579,257
Market Cap5.68B
Beta1.38
PE Ratio (TTM)9.18
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • See what the IHS Markit Score report has to say about United Therapeutics Corp.
    Markit2 days ago

    See what the IHS Markit Score report has to say about United Therapeutics Corp.

    The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.

  • United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : August 21, 2017
    Capital Cube3 days ago

    United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : August 21, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for United Therapeutics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • American City Business Journals9 days ago

    United Therapeutics, Mayo Clinic to build lung restoration facility in Florida

    The facility, expected to take about two years to complete, is part of Mayo's broader plan to make the campus a destination medical facility, the Jacksonville Business Journal reported earlier this year . It's also part of an expanding focus for Silver Spring-based United Therapeutics (UTHR), which mainly focuses on creating pulmonary hypertension drugs.